Infinera (INFN) 10-Q 29 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 27, 2014	Oct. 22, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	27-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'INFN	'
Entity Registrant Name	'INFINERA CORP	'
Entity Central Index Key	'0001138639	'
Current Fiscal Year End Date	'--12-27	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	125,286,347

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$110,864	$124,330
Short-term investments	206,713	172,660
Accounts receivable, net of allowance for doubtful accounts of $20 in 2014 and $43 in 2013	136,085	100,643
Inventory	130,833	123,685
Prepaid expenses and other current assets	21,714	17,752
Total current assets	606,209	539,070
Property, plant and equipment, net	74,964	79,668
Long-term investments	55,886	64,419
Cost-method investment	14,500	9,000
Long-term restricted cash	4,224	3,904
Other non-current assets	5,309	4,865
Total assets	761,092	700,926
Current liabilities:	'	'
Accounts payable	51,456	39,843
Accrued expenses	23,593	22,431
Accrued compensation and related benefits	29,632	33,899
Accrued warranty	12,736	12,374
Deferred revenue	24,386	32,402
Total current liabilities	141,803	140,949
Long-term debt, net	114,888	109,164
Accrued warranty, non-current	15,070	10,534
Deferred revenue, non-current	8,633	4,888
Other long-term liabilities	18,741	17,581
Commitments and contingencies (Note 14)	'	'
Stockholders’ equity:	'	'
Preferred stock, $0.001 par value Authorized shares – 25,000 and no shares issued and outstanding	0	0
Issued and outstanding shares – 125,267 as of September 27, 2014 and 119,887 as of December 28, 2013	125	120
Additional paid-in capital	1,064,723	1,025,661
Accumulated other comprehensive loss	-3,655	-3,486
Accumulated deficit	-599,236	-604,485
Total stockholders’ equity	461,957	417,810
Total liabilities and stockholders’ equity	$761,092	$700,926

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Net of allowance for doubtful accounts	$20	$43
Preferred stock, par value (USD per share)	$0.00	$0.00
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (USD per share)	$0.00	$0.00
Common stock, authorized shares	500,000,000	500,000,000
Common stock, shares issued	125,267,000	119,887,000
Common stock, shares outstanding	125,267,000	119,887,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Revenue:	'	'	'	'
Product	$147,178	$121,332	$413,784	$350,322
Services	26,381	20,688	67,989	54,708
Total revenue	173,559	142,020	481,773	405,030
Cost of revenue:	'	'	'	'
Cost of product	86,703	66,685	251,047	222,330
Cost of services	11,554	6,964	26,765	19,973
Total cost of revenue	98,257	73,649	277,812	242,303
Gross profit	75,302	68,371	203,961	162,727
Operating expenses:	'	'	'	'
Research and development	35,051	32,528	96,135	93,935
Sales and marketing	20,794	17,720	56,738	52,921
General and administrative	11,977	11,678	36,612	32,976
Total operating expenses	67,822	61,926	189,485	179,832
Income (loss) from operations	7,480	6,445	14,476	-17,105
Other income (expense), net:	'	'	'	'
Interest income	373	232	1,046	636
Interest expense	-2,781	-2,578	-8,186	-3,427
Other gain (loss), net	-24	-444	-1,017	-805
Total other income (expense), net	-2,432	-2,790	-8,157	-3,596
Income (loss) before income taxes	5,048	3,655	6,319	-20,701
Provision for income taxes	205	308	1,070	1,240
Net income (loss)	$4,843	$3,347	$5,249	($21,941)
Net income (loss) per common share:	'	'	'	'
Basic (USD per share)	$0.04	$0.03	$0.04	($0.19)
Diluted (USD per share)	$0.04	$0.03	$0.04	($0.19)
Weighted average shares used in computing net income (loss) per common share:	'	'	'	'
Basic weighted average common shares outstanding (in shares)	124,378	118,740	122,953	116,653
Diluted weighted average common shares outstanding (in shares)	128,964	124,679	127,062	116,653

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income (loss)	$4,843	$3,347	$5,249	($21,941)
Other comprehensive income (loss):	'	'	'	'
Reclassification of realized gain on auction rate securities	0	0	0	-166
Unrealized gain (loss) on all other available-for-sale investments	-90	44	-27	-64
Foreign currency translation adjustment	-473	-98	-142	-1,016
Tax related to available-for-sale investment	20	0	0	0
Net change in accumulated other comprehensive income (loss)	-543	-54	-169	-1,246
Comprehensive income (loss)	$4,300	$3,293	$5,080	($23,187)

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013
Cash Flows from Operating Activities:	'	'
Net income (loss)	$5,249	($21,941)
Adjustments to reconcile net income (loss) to net cash used in operating activities:	'	'
Depreciation and amortization	19,340	18,574
Amortization of debt discount and issuance costs	6,217	2,552
Amortization of premium on investments	2,720	870
Stock-based compensation expense	20,847	23,802
Other loss (gain)	15	-278
Changes in assets and liabilities:	'	'
Accounts receivable	-35,463	19,805
Inventory	-9,015	-3,603
Prepaid expenses and other assets	-4,965	-6,427
Accounts payable	11,009	-30,624
Accrued liabilities and other expenses	657	1,640
Deferred revenue	-4,272	-1,655
Accrued warranty	4,898	6,680
Net cash provided by operating activities	17,237	9,395
Cash Flows from Investing Activities:	'	'
Purchase of available-for-sale investments	-214,272	-206,528
Purchase of cost-method investment	-5,500	0
Proceeds from sale of available-for-sale investments	17,876	2,850
Proceeds from maturities and calls of investments	168,137	77,143
Purchase of property and equipment	-14,364	-13,605
Change in restricted cash	-320	110
Net cash used in investing activities	-48,443	-140,030
Cash Flows from Financing Activities:	'	'
Proceeds from issuance of debt, net	0	144,469
Proceeds from issuance of common stock	19,683	21,551
Minimum tax withholding paid on behalf of employees for net share settlement	-1,846	-1,541
Net cash provided by financing activities	17,837	164,479
Effect of exchange rate changes on cash	-97	-881
Net change in cash and cash equivalents	-13,466	32,963
Cash and cash equivalents at beginning of period	124,330	104,666
Cash and cash equivalents at end of period	110,864	137,629
Supplemental disclosures of cash flow information:	'	'
Cash paid for income taxes, net of refunds	1,056	1,536
Cash paid for interest	1,313	0
Supplemental schedule of non-cash financing activities:	'	'
Transfer of inventory to fixed assets	$1,838	$6,672

Basis_of_Presentation_and_Sign

Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 27, 2014
Accounting Policies [Abstract]	'
Basis of Presentation and Significant Accounting Policies	'
	Basis of Presentation and Significant Accounting Policies
	Infinera Corporation (the "Company") prepared its interim condensed consolidated financial statements that accompany these notes in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"), consistent in all material respects with those applied in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2013.
	The Company has made certain estimates, assumptions and judgments that can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Significant estimates, assumptions and judgments made by management include revenue recognition, stock-based compensation, inventory valuation, allowances for sales returns, allowances for doubtful accounts, accrued warranty, fair value measurement of the liability component of the convertible senior notes, fair value measurement of cash equivalents, investments and derivative instruments, other-than-temporary impairments and accounting for income taxes. Management believes that the estimates and judgments upon which they rely are reasonable based upon information available to them at the time that these estimates and judgments are made. To the extent there are material differences between these estimates and actual results, the Company’s consolidated financial statements will be affected.
	The interim financial information is unaudited, but reflects all adjustments that are, in management’s opinion, necessary to provide a fair presentation of results for the interim periods presented. All adjustments are of a normal recurring nature. The Company reclassified certain amounts reported in previous periods to conform to the current presentation. This interim information should be read in conjunction with the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2013.
	There have been no material changes in the Company’s significant accounting policies for the nine months ended September 27, 2014 as compared to those disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2013.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Sep. 27, 2014
Accounting Changes and Error Corrections [Abstract]	'
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In July 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2013-11, "Income Taxes - Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry Forward, a Similar Tax Loss, or a Tax Credit Carry Forwards Exists" ("ASU 2013-11"). ASU 2013-11 requires entities to present the unrecognized tax benefits in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. ASU 2013-11 is effective for annual and interim periods for fiscal years beginning on or after December 15, 2013. The Company's adoption of ASU 2013-11 during the first quarter of 2014 had no impact on the Company’s financial position, results of operations or cash flow.
	In May 2014, the FASB issued Accounting Standards Update 2014-09, "Revenue from Contracts from Customers" ("ASU 2014-09"). ASU 2014-09 provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 will require an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This update creates a five-step model that requires entities to exercise judgment when considering the terms of the contract(s) which include (i) identifying the contract(s) with the customer; (ii) identifying the separate performance obligations in the contract; (iii) determining the transaction price; (iv) allocating the transaction price to the separate performance obligations; and (v) recognizing revenue when each performance obligation is satisfied. ASU 2014-09 will be effective for the Company’s first quarter of 2017. The Company has the option to apply the provisions of ASU 2014-09 either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of applying this ASU recognized at the date of initial application. Early adoption is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company's condensed consolidated financial statements.
	In June 2014, the FASB issued Accounting Standards Update No. 2014-12, "Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period" ("ASU 2014-12"). ASU 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Accounting Standard Codification ("ASC") 718, "Compensation—Stock Compensation" ("ASC 718"), as it relates to such awards. ASU 2014-12 is effective for us in our first quarter of fiscal 2017 with early adoption permitted using either of two methods: (i) prospective to all awards granted or modified after the effective date; or (ii) retrospective to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter, with the cumulative effect of applying ASU 2014-12 as an adjustment to the opening retained earnings balance as of the beginning of the earliest annual period presented in the financial statements. The Company is currently evaluating the impact of the pending adoption of ASU 2014-12 on its condensed consolidated financial statements.
	In August 2014, the FASB issued Accounting Standards Update No. 2014-15, "Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern" ("ASU 2014-15"). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for the Company in its fourth quarter of fiscal 2017 with early adoption permitted. The Company is currently evaluating the impact of the pending adoption of ASU 2014-15 on its condensed consolidated financial statements.

Fair_Value_Measurements_and_Ot

Fair Value Measurements and Other-Than-Temporary Impairments	9 Months Ended
	Sep. 27, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements and Other-Than-Temporary Impairments	'
	Fair Value Measurements and Other-Than-Temporary Impairments
	Fair Value Measurements
	Pursuant to the accounting guidance for fair value measurements and its subsequent updates, fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
	Valuation techniques used by the Company are based upon observable and unobservable inputs. Observable or market inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s assumptions about market participant assumptions based on the best information available. Observable inputs are the preferred source of values. These two types of inputs create the following fair value hierarchy:
	Level 1		–		Quoted prices in active markets for identical assets or liabilities.
	Level 2		–		Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3		–		Prices or valuations that require management inputs that are both significant to the fair value measurement and unobservable.
	The Company measures its cash equivalents, foreign currency exchange forward contracts and debt securities at fair value and classifies its securities in accordance with the fair value hierarchy. The Company’s money market funds and U.S. treasuries are classified within Level 1 of the fair value hierarchy and are valued based on quoted prices in active markets for identical securities.
	The Company classifies its certificates of deposit, commercial paper, corporate bonds and foreign currency exchange forward contracts within Level 2 of the fair value hierarchy as follows:
	Certificates of Deposit
	The Company reviews market pricing and other observable market inputs for the same or similar securities obtained from a number of industry standard data providers. In the event that a transaction is observed for the same or similar security in the marketplace, the price on that transaction reflects the market price and fair value on that day. In the absence of any observable market transactions for a particular security, the fair market value at period end would be equal to the par value. These inputs represent quoted prices for similar assets or these inputs have been derived from observable market data.
	Commercial Paper
	The Company reviews market pricing and other observable market inputs for the same or similar securities obtained from a number of industry standard data providers. In the event that a transaction is observed for the same or similar security in the marketplace, the price on that transaction reflects the market price and fair value on that day and then follows a revised accretion schedule to determine the fair market value at period end. In the absence of any observable market transactions for a particular security, the fair market value at period end is derived by accreting from the last observable market price. These inputs represent quoted prices for similar assets or these inputs have been derived from observable market data accreted mathematically to par.
	Corporate Bonds
	The Company reviews trading activity and pricing for each of the corporate bond securities in its portfolio as of the measurement date and determines if pricing data of sufficient frequency and volume in an active market exists in order to support Level 1 classification of these securities. If sufficient quoted pricing for identical securities is not available, the Company obtains market pricing and other observable market inputs for similar securities from a number of industry standard data providers. In instances where multiple prices exist for similar securities, these prices are used as inputs into a distribution-curve to determine the fair market value at period end.
	Foreign Currency Exchange Forward Contracts
	As discussed in Note 5, "Derivative Instruments," to the Notes to Condensed Consolidated Financial Statements, the Company mainly holds non-speculative foreign exchange forward contracts to hedge certain foreign currency exchange exposures. The Company estimates the fair values of derivatives based on quoted market prices or pricing models using current market rates. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit risk, foreign exchange rates, and forward and spot prices for currencies.
	The following tables represent the Company’s fair value hierarchy for its assets and liabilities measured at fair value on a recurring basis (in thousands):
		As of September 27, 2014															As of December 28, 2013
		Fair Value Measured Using															Fair Value Measured Using
		Level 1				Level 2			Level 3				Total				Level 1				Level 2		Level 3		Total
	Assets
	Money market funds	$	15,369			$	—		$	—			$	15,369			$	51,749			$	—	$	—	$	51,749
	Certificates of deposit	—				3,460			—				3,460				—				3,840		—		3,840
	Commercial paper	—				83,838			—				83,838				—				85,860		—		85,860
	Corporate bonds	—				202,804			—				202,804				—				150,595		—		150,595
	U.S. treasuries	8,833				—			—				8,833				4,804				—		—		4,804
	Foreign currency exchange forward contracts	—				—			—				—				—				29		—		29
	Total assets	$	24,202			$	290,102		$	—			$	314,304			$	56,553			$	240,324	$	—	$	296,877
	Liabilities
	Foreign currency exchange forward contracts	$	—			$	32		$	—			$	32			$	—			$	26	$	—	$	26
	During the three and nine months ended September 27, 2014, there were no transfers of assets or liabilities between Level 1 and Level 2.
	Investments at fair value were as follows (in thousands):
		27-Sep-14
		Adjusted Amortized Cost				Gross Unrealized Gains			Gross Unrealized				Fair Value
									Losses
	Money market funds	$	15,369			$	—		$	—			$	15,369
	Certificates of deposit	3,460				—			—				3,460
	Commercial paper	83,838				2			(2		)		83,838
	Corporate bonds	202,959				19			(174		)		202,804
	U.S. treasuries	8,829				5			(1		)		8,833
	Total available-for-sale investments	$	314,455			$	26		$	(177	)		$	314,304
		December 28, 2013
		Adjusted Amortized Cost				Gross Unrealized Gains			Gross Unrealized Losses				Fair Value
	Money market funds	$	51,749			$	—		$	—			$	51,749
	Certificates of deposit	3,840				—			—				3,840
	Commercial paper	85,870				2			(12		)		85,860
	Corporate bonds	150,711				27			(143		)		150,595
	U.S. treasuries	4,802				2			—				4,804
	Total available-for-sale investments	$	296,972			$	31		$	(155	)		$	296,848
	As of September 27, 2014, the Company’s available-for-sale investments have a contractual maturity term of no more than 18 months. Net realized gains (losses) on short-term and long-term investments for the three and nine months ended September 27, 2014 were insignificant in both periods. Net realized gains (losses) on short-term and long-term investments were zero and $0.2 million for the three and nine months ended September 28, 2013, respectively. The specific identification method is used to account for gains and losses on available-for-sale investments.
	As of September 27, 2014 and December 28, 2013, the Company held $59.2 million and $64.6 million of cash in banks, respectively.
	Other-Than-Temporary Impairments
	As a result of the Company’s disposal of $3.1 million of its remaining auction rate securities (par value) during the first quarter of 2013, it recorded an approximately $0.2 million gain, which was recognized as other gain (loss), net, in the Company’s condensed consolidated statements of operations.
	A roll-forward of amortized cost, cumulative other-than-temporary impairments ("OTTI") recognized in earnings and accumulated other comprehensive loss for the nine months ended September 28, 2013 were as follows (in thousands):
		Amortized				Cumulative				Unrealized				OTTI Loss in				Accumulated
		Cost				OTTI in				Gain				Accumulated				Other
						Earnings								Other				Comprehensive
														Comprehensive				Income (Loss)
														Loss
	Balance at December 29, 2012	$	2,707			$	(394	)		$	784			$	(618	)		$	166
	Call on investments	(87		)		13				(25		)		20				(5		)
	Investments sold	(2,620		)		381				(759		)		598				(161		)
Balance at September 28, 2013	$	—			$	—			$	—			$	—			$	—

Costmethod_Investment

Cost-method Investment	9 Months Ended
	Sep. 27, 2014
Investments, All Other Investments [Abstract]	'
Cost-method Investment	'
	Cost-method Investment
	During the three months ended September 27, 2014, the Company invested an additional $5.5 million in an existing cost-method equity investment. As of September 27, 2014, the Company’s investment in a privately-held company was $14.5 million. This investment is accounted for as a cost-method investment, as the Company owns less than 20% of the voting securities and does not have the ability to exercise significant influence over operating and financial policies of the entity. The Company’s cost-method investment is carried at historical cost in its condensed consolidated financial statements and measured at fair value on a nonrecurring basis. If the Company believes that the carrying value of the cost basis investment is in excess of estimated fair value, the Company’s policy is to record an impairment charge in other income (expense), net, in the accompanying condensed consolidated statements of operations to adjust the carrying value to estimated fair value, when the impairment is deemed other-than-temporary. The Company regularly evaluates the carrying value of this cost-method investment for impairment. As of September 27, 2014, no event had occurred that would adversely affect the carrying value of this investment, therefore, the fair value of the cost-method investment is not estimated. The Company did not record any impairment charges for this cost-method investment during the three and nine months ended September 27, 2014 and September 28, 2013.

Derivative_Instruments

Derivative Instruments	9 Months Ended
	Sep. 27, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments	'
	Derivative Instruments
	Foreign Currency Exchange Forward Contracts
	The Company enters into foreign currency exchange forward contracts to manage its exposure to fluctuations in foreign exchange rates that arise primarily from its euro and British pound denominated receivables and euro denominated restricted cash balance amounts that are pledged as collateral for certain stand-by and commercial letters of credit. Gains and losses on these contracts are intended to offset the impact of foreign exchange rate fluctuations on the underlying foreign currency denominated accounts receivables and restricted cash, and therefore, do not subject the Company to material balance sheet risk. The forward contracts are with one high-quality institution and the Company consistently monitors the creditworthiness of the counterparty. The forward contracts entered into during the three and nine months ended September 27, 2014 were denominated in euros and British pounds, and had maturities of no more than 35 days. The contracts are settled for U.S. dollars at maturity at rates agreed to at inception of the contracts.
	As of September 27, 2014, the Company did not designate foreign currency exchange forward contracts as hedges for accounting purposes, and accordingly changes in the fair value of these instruments are included in other gain (loss), net, in the accompanying condensed consolidated statements of operations. For the three months ended September 27, 2014 and September 28, 2013, the before-tax effect of foreign currency exchange forward contracts was a gain of $1.2 million and a loss of $1.2 million, respectively. For the nine months ended September 27, 2014 and September 28, 2013, the before-tax effect of foreign currency exchange forward contracts was a gain of $0.8 million and a loss of $1.4 million, respectively.
	The fair value of derivative instruments not designated as hedging instruments in the Company’s condensed consolidated balance sheets was as follows (in thousands):
		As of September 27, 2014							As of December 28, 2013
		Gross Notional(1)		Prepaid Expenses and Other Assets		Other			Gross Notional(1)		Prepaid Expenses and Other Assets		Other
						Accrued							Accrued
						Liabilities							Liabilities
	Foreign currency exchange forward contracts
	Related to euro denominated receivables	$	20,980	—		$	(30	)	$	16,867	27		$	—
	Related to British pound denominated receivables	165		—		—			13,271		—		(26		)
	Related to restricted cash	1,287		—		(2		)	1,391		2		—
		$	22,432	$	—	$	(32	)	$	31,529	$	29	$	(26	)
	_________________
	(1)	Represents the face amounts of forward contracts that were outstanding as of the period noted.

Balance_Sheet_Details

Balance Sheet Details	9 Months Ended
	Sep. 27, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Balance Sheet Details	'
	Balance Sheet Details
	The following table provides details of selected balance sheet items (in thousands):
		27-Sep-14			28-Dec-13
	Inventory:
	Raw materials	$	11,584		$	14,311
	Work in process	44,462			49,172
	Finished goods (1)	74,787			60,202
	Total inventory	$	130,833		$	123,685
	Property, plant and equipment, net:
	Computer hardware	$	8,515		$	9,692
	Computer software(2)	17,679			16,988
	Laboratory and manufacturing equipment	158,446			146,834
	Furniture and fixtures	1,343			1,347
	Leasehold improvements	37,258			35,913
	Construction in progress	6,465			8,950
	Subtotal	$	229,706		$	219,724
	Less accumulated depreciation and amortization	(154,742		)	(140,056		)
	Total property, plant and equipment, net	$	74,964		$	79,668
	Accrued expenses:
	Loss contingency related to non-cancelable purchase commitments	$	6,242		$	5,120
	Professional and other consulting fees	1,033			1,411
	Taxes payable	1,620			2,372
	Royalties	2,152			1,540
	Accrued rebate and customer prepay liability	758			3,807
	Accrued interest on convertible senior notes	875			219
	Other accrued expenses	10,913			7,962
	Total accrued expenses	$	23,593		$	22,431
	_________________
	(1)	Included in finished goods inventory at September 27, 2014 and December 28, 2013 were $16.2 million and $9.2 million, respectively, of inventory at customer locations for which product acceptance had not occurred.
	(2)	Included in computer software at September 27, 2014 and December 28, 2013 were $7.9 million and $7.9 million, respectively, related to an enterprise resource planning ("ERP") system that the Company implemented during 2012. The unamortized ERP costs at September 27, 2014 and December 28, 2013 were $5.4 million and $6.3 million, respectively.
	Restricted Cash
	The Company’s long-term restricted cash balance is primarily comprised of certificates of deposit, of which the majority is not insured by the Federal Deposit Insurance Corporation. These amounts primarily collateralize the Company’s issuances of stand-by and commercial letters of credit. Additionally, the Company’s restricted cash balance includes a leave encashment fund for India employees and a corporate bank card deposit for employees in the United Kingdom.
	The following table sets forth the Company's restricted cash (in thousands):
		27-Sep-14			28-Dec-13
	Restricted cash related to outstanding standby letters of credit
	Value added tax license	$	1,362		$	1,430
	Customer proposal guarantee	1,771			1,446
	Property leases	699			699
	Other	392			329
	Total restricted cash	$	4,224		$	3,904

Accumulated_Comprehensive_Loss

Accumulated Comprehensive Loss	9 Months Ended
	Sep. 27, 2014
Equity [Abstract]	'
Accumulated Comprehensive Loss	'
	Accumulated Comprehensive Loss
	Other comprehensive loss includes certain changes in equity that are excluded from net income (loss). The following table sets forth the changes in accumulated other comprehensive loss by component for the nine months ended September 27, 2014 (in thousands):
		Unrealized Gain			Foreign			Accumulated			Total
		on Other			Currency Translation			Tax Effect
		Available-for-Sale
		Securities
	Balance at December 28, 2013	$	(124	)	$	(2,602	)	$	(760	)	$	(3,486	)
	Net current-period other comprehensive loss	(27		)	(142		)	—			(169		)
	Balance at September 27, 2014	$	(151	)	$	(2,744	)	$	(760	)	$	(3,655	)

Basic_and_Diluted_Net_Income_L

Basic and Diluted Net Income (Loss) Per Common Share	9 Months Ended
	Sep. 27, 2014
Earnings Per Share [Abstract]	'
Basic and Diluted Net Income (Loss) Per Common Share	'
	Basic and Diluted Net Income (Loss) Per Common Share
	Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is computed using net income (loss) and the weighted average number of common shares outstanding plus potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include the assumed exercise of outstanding stock options, assumed vesting of outstanding restricted stock units ("RSUs") and performance stock units ("PSUs"), assumed conversion of convertible senior notes from the conversion spread, and assumed issuance of stock under the Company’s Employee Stock Purchase Plan ("ESPP") using the treasury stock method. The Company includes the common shares underlying PSUs in the calculation of diluted net income per share only when they become contingently issuable. In net loss periods, these potentially diluted common shares are anti-dilutive and therefore, excluded from the diluted net loss calculation.
	The following table sets forth the computation of net income (loss) per common share – basic and diluted (in thousands, except per share amounts):
		Three Months Ended						Nine Months Ended
		27-Sep-14			28-Sep-13			27-Sep-14		28-Sep-13
	Numerator:
	Net income (loss)	$	4,843		$	3,347		$	5,249	$	(21,941	)
	Denominator:
	Basic weighted average common shares outstanding	124,378			118,740			122,953		116,653
	Effect of dilutive securities:
	Employee equity plans	4,586			5,939			4,109		—
	Diluted weighted average common shares outstanding	128,964			124,679			127,062		116,653
	Net income (loss) per common share
	Basic	$	0.04		$	0.03		$0.04		$	(0.19	)
	Diluted	$	0.04		$	0.03		$0.04		$	(0.19	)
	The number of shares outstanding used in the computation of basic and diluted net income (loss) per share does not include the effect of the potential outstanding common stock listed in the following table. The effects of these potentially outstanding shares were not included in the calculation of diluted net income (loss) per share because their effect would have been anti-dilutive under the treasury stock method or the performance condition of the award has not been met (in thousands):
		Three Months Ended					Nine Months Ended
		27-Sep-14		28-Sep-13			27-Sep-14		28-Sep-13
	Stock options	447		408			706		6,603
	Restricted stock units	68		89			250		6,559
	Performance stock units	185		211			185		721
	Employee stock purchase plan shares	801		675			921		675
	Total	1,501		1,383			2,062		14,558
	In the three and nine months ended September 27, 2014, and in the three months ended September 28, 2013, the Company excluded the potential shares issuable upon early conversion of the convertible senior notes in the calculation of diluted earnings per share because the market price was below the conversion price. In the future, the Company would include these dilutive effects of the convertible senior notes in the calculation of diluted net income per common share if the market price is above the conversion price. Upon conversion of the convertible senior notes, it is the Company’s intention to pay cash equal to the lesser of the aggregate principal amount or the conversion value of the notes being converted, therefore, only the conversion spread relating to the notes would be included in the Company’s diluted earnings per share calculation unless their effect is anti-dilutive.

Convertible_Senior_Notes

Convertible Senior Notes	9 Months Ended
	Sep. 27, 2014
Debt Disclosure [Abstract]	'
Convertible Senior Notes	'
	Convertible Senior Notes
	In May 2013, the Company issued $150.0 million of 1.75% convertible senior notes due June 1, 2018 (the “Notes”). The Notes will mature on June 1, 2018, unless earlier purchased by the Company or converted. Interest is payable semi-annually in arrears on June 1 and December 1 of each year, commencing December 1, 2013. The net proceeds to the Company were approximately $144.5 million.
	The Notes are governed by an indenture dated as of May 30, 2013 (the "Indenture"), between the Company, as issuer, and U.S. Bank National Association, as trustee. The Notes are unsecured and do not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness, or the issuance or repurchase of securities by the Company.
	Upon conversion, it is the Company’s intention to pay cash equal to the lesser of the aggregate principal amount or the conversion value of the Notes as cash, shares of common stock or a combination of cash and shares of common stock, at the Company’s election, for any remaining conversion obligation. The initial conversion rate is 79.4834 shares of common stock per $1,000 principal amount of Notes, subject to anti-dilution adjustments. The initial conversion price is approximately $12.58 per share of common stock.
	Throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events, including for any cash dividends. Holders of the Notes will not receive any cash payment representing accrued and unpaid interest upon conversion of a Note. Accrued but unpaid interest will be deemed to be paid in full upon conversion rather than canceled, extinguished or forfeited. Holders may convert their Notes under the following circumstances:
	•	during any fiscal quarter commencing after the fiscal quarter ended on September 28, 2013 (and only during such fiscal quarter) if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
	•	during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day;
	•	upon the occurrence of specified corporate events described under the Indenture, such as a consolidation, merger or binding share exchange; or
	•	at any time on or after December 1, 2017 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances.
	If the Company undergoes a fundamental change as defined in the Indenture governing the Notes, holders may require the Company to repurchase for cash all or any portion of their Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, upon the occurrence of a “make-whole fundamental change” (as defined in the Indenture), the Company will, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert its Notes in connection with such make-whole fundamental change.
	The amounts recorded in connection with the issuance of the Notes and related amortization consisted of the following (in thousands):
		Other Non-Current Assets			Long-Term Debt			Additional Paid-in Capital
	Principal amount	$	—		$	150,000		$	—
	Debt discount	—			(45,000		)	—
	Equity component	—			—			45,000
	Debt issuance cost	3,872			—			(1,659		)
	Initial transaction amounts	$	3,872		$	105,000		$	43,341
	Amortization of debt issuance cost	(851		)	—			—
	Amortization of debt discount	—			9,888			—
	Net carrying amount at September 27, 2014	$	3,021		$	114,888		$	43,341
	In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount ("debt discount") is amortized to interest expense over the term of the Notes. The remaining debt discount amount to be amortized over the remaining years until maturity of the Notes was $35.1 million as of September 27, 2014.
	In accounting for the issuance costs of $5.5 million related to the Notes, the Company allocated the total amount incurred to the liability and equity components of the Notes based on their relative values. Issuance costs attributable to the liability component were recorded as other non-current assets and will be amortized to interest expense over the term of the Notes. The issuance costs attributable to the equity component were netted with the equity component in stockholders’ equity. Additionally, the Company initially recorded a deferred tax liability of $17.0 million in connection with the issuance of the Notes, and a corresponding reduction in valuation allowance. The impact of both was recorded to stockholders’ equity.
	The Company determined that the embedded conversion option in the Notes does not require separate accounting treatment as a derivative instrument because it is both indexed to the Company’s own stock and would be classified in stockholder’s equity if freestanding.
	The following table sets forth total interest expense recognized related to the Notes (in thousands):
		Three Months Ended						Nine Months Ended
		27-Sep-14			28-Sep-13			27-Sep-14			28-Sep-13
	Contractual interest expense	$	656		$	656		$	1,969		$	875
	Amortization of debt issuance costs	169			152			493			202
	Amortization of debt discount	1,956			1,770			5,724			2,350
	Total interest expense	$	2,781		$	2,578		$	8,186		$	3,427
	The coupon rate was 1.75%. The debt discount and debt issuance costs are amortized, using an annual effective interest rate of 10.23%, to interest expense over the term of the Notes.
	As of September 27, 2014, the fair value of the Notes was $167.3 million. The fair value was determined based on the quoted bid price of the Notes in an over-the-counter market on September 26, 2014. The Notes are classified as Level 2 of the fair value hierarchy. Based on the closing price of the Company’s common stock of $10.61 on September 26, 2014, the if-converted value of the Notes was less than their principal amount.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 27, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stockholders' Equity	'
	Stockholders’ Equity
	Stock-based Compensation Plans
	The Company has stock-based compensation plans pursuant to which the Company has granted stock options, RSUs and PSUs. The Company also has an ESPP for all eligible employees. As of September 27, 2014, there were a total of 17.5 million shares of common stock available for grant under the Company’s 2007 Equity Incentive Plan ("2007 Plan"). The following tables summarize the Company’s equity award activity and related information (in thousands, except per share data):
		Number of Stock			Weighted-Average				Aggregate
		Options			Exercise				Intrinsic
					Price				Value
					Per Share
	Outstanding at December 28, 2013	6,367			$	7.26			$	17,452
	Stock options granted	25			$	9.02
	Stock options exercised	(1,280	)		$	6.99			$	3,210
	Stock options canceled	(92	)		$	12.39
	Outstanding at September 27, 2014	5,020			$	7.24			$	17,631
	Vested and expected to vest as of September 27, 2014	5,017							$	17,622
	Exercisable at September 27, 2014	4,921			$	7.24			$	17,329
		Number of			Weighted-				Aggregate
		Restricted			Average				Intrinsic
		Stock Units			Grant Date				Value
					Fair Value
					Per Share
	Outstanding at December 28, 2013	6,583			$	7.72			$	64,443
	RSUs granted	2,415			$	8.37
	RSUs released	(2,625	)		$	7.74			$	22,477
	RSUs canceled	(424	)		$	7.88
	Outstanding at September 27, 2014	5,949			$	7.97			$	63,122
	Expected to vest at September 27, 2014	5,751							$	61,021
		Number of			Weighted-				Aggregate
		Performance			Average				Intrinsic
		Stock Units			Grant Date				Value
					Fair Value
					Per Share
	Outstanding at December 28, 2013	721			$	7.04			$	7,054
	PSUs granted	508			$	7.53
	PSUs released	(255	)		$	6.36			$	2,097
	PSUs canceled	(97	)		$	7.18
	Outstanding at September 27, 2014	877			$	7.49			$	9,298
	Expected to vest at September 27, 2014	659							$	6,994
	The aggregate intrinsic value of unexercised stock options is calculated as the difference between the closing price of the Company’s common stock of $10.61 at September 26, 2014 and the exercise prices of the underlying stock options. The aggregate intrinsic value of the stock options that have been exercised is calculated as the difference between the fair market value of the common stock at the date of exercise and the exercise price of the underlying stock options. The aggregate intrinsic value of unreleased RSUs and unreleased PSUs is calculated using the closing price of the Company's common stock of $10.61 at September 26, 2014. The aggregate intrinsic value of RSUs and PSUs released is calculated using the fair market value of the common stock at the date of release.
	The following table presents total stock-based compensation cost for instruments granted but not yet amortized, net of estimated forfeitures, of the Company’s equity compensation plans as of September 27, 2014. These costs are expected to be amortized on a straight-line basis over the following weighted-average periods (in thousands, except for weighted-average period):
		Unrecognized			Weighted-
		Compensation			Average Period
		Expense, Net			(in years)
	Stock options	317			1.5
	RSUs	30,599			2.3
	PSUs	2,704			1.6
	Employee Stock Options
	The estimated values of stock options, as well as assumptions used in calculating these values were based on estimates as follows (expense amounts in thousands):
		Three Months Ended				Nine Months Ended
	Employee and Director Stock Options	27-Sep-14		28-Sep-13		27-Sep-14		28-Sep-13
	Volatility	N/A		N/A		52%		N/A
	Risk-free interest rate	N/A		N/A		1.30%		N/A
	Expected life	N/A		N/A		4.3 years		N/A
	Estimated fair value	N/A		N/A		$3.85		N/A
	Total stock-based compensation expense	$108		$665		$623		$2,190
	_________________
	N/A	Not applicable because the Company did not grant any stock options to employees for the periods presented.
	Employee Stock Purchase Plan
	The fair value of the ESPP shares was estimated at the date of grant using the following assumptions (expense amounts in thousands):
		Three Months Ended				Nine Months Ended
	Employee Stock Purchase Plan	27-Sep-14		28-Sep-13		27-Sep-14		28-Sep-13
	Volatility	46%		49%		46% - 51%		46% - 49%
	Risk-free interest rate	0.06%		0.10%		0.02% - 0.11%		0.10% - 0.14%
	Expected life	0.5 years		0.5 years		0.25 - 0.5 years		0.5 years
	Estimated fair value	$2.54		$3.00		$2.05 - $2.57		$1.87 - $3.00
Total stock-based compensation expense	$1,092		$777		$2,726		$2,050
Restricted Stock Units
During the three and nine months ended September 27, 2014, the Company granted RSUs to employees and members of the Company’s board of directors to receive an aggregate of 0.1 million shares and 2.4 million shares of the Company’s common stock, respectively. The Company accounted for the fair value of the RSUs using the closing market price of the Company’s common stock on the date of grant. Amortization of stock-based compensation related to RSUs in the three and nine months ended September 27, 2014 and September 28, 2013 was approximately $5.6 million and $15.9 million, respectively, and approximately $5.5 million and $18.2 million, respectively.
Performance Stock Units
Pursuant to the 2007 Plan, during fiscal 2012, the Company granted 0.5 million shares of PSUs to certain of its executive officers. These PSUs will only vest upon the achievement of certain specific revenue and operating profit criteria and are subject to each named executive officer’s continued service to the Company. If the financial performance metrics are not met within the time limits specified in the award agreements, the PSUs will be canceled. During the three and nine months ended September 27, 2014, the Company did not release any shares subject to these PSUs.
Pursuant to the 2007 Plan, during fiscal 2013, the Company granted 0.6 million shares of PSUs to certain of its executive officers. The number of shares to be issued upon vesting of PSUs range from 0 to 1.5 times the number of PSUs granted depending on the relative performance of the Company’s common stock price compared to the NASDAQ Telecom Composite Index over the span of one, two and three years of total shareholder returns. During the three and nine months ended September 27, 2014, the Company released zero shares and 0.3 million shares of PSUs, respectively, based on a payout of 1.5 times of the target number of PSUs.
The ranges of estimated values of the PSUs granted, as well as assumptions used in calculating these values were based on estimates as follows:
	Year Ended
	28-Dec-13
Infinera Volatility	55%
NASDAQ Telecom Composite Index Volatility	23%
Risk-free interest rate	0.42%
Correlation with NASDAQ Telecom Composite Index	0.56
Estimated fair value	$6.27 - $7.06
Pursuant to the 2007 Plan, during the three and nine months ended September 27, 2014, the Company granted zero shares and 0.4 million shares of PSUs, respectively, to certain of its executive officers. The number of shares to be issued upon vesting of PSUs range from 0 to 1.5 times the number of PSUs granted depending on the relative performance of the Company's common stock price compared to the iShares North American Tech-Multimedia Networking ("IGN") Index over the span of one, two and three years of total shareholder returns.
The ranges of estimated values of the PSUs granted, as well as assumptions used in calculating these values were based on estimates as follows:
		Nine Months Ended
		27-Sep-14
Infinera Volatility		49% - 50%
IGN Index Volatility		25%
Risk-free interest rate		0.66% - 0.71%
Correlation with IGN Index		0.6
Estimated fair value		$6.59 - $7.60
Pursuant to the 2007 Plan, during the three months ended September 27, 2014, the Company granted 0.1 million shares of PSUs to several employees. These PSUs will only vest upon the achievement of certain specific performance criteria and are subject to each employee's continued service to the Company. If the specific performance metrics are not met within the time limits specified in the award agreements, the PSUs will be cancelled.
Amortization of stock-based compensation related to PSUs in the three and nine months ended September 27, 2014 was approximately $0.6 million and $1.5 million, respectively. Amortization of stock-based compensation related to PSUs in the three months ended September 28, 2013 was approximately $0.5 million. Amortization of stock-based compensation in the nine months ended September 28, 2013 was approximately $0.1 million, including $1.5 million of expense offset by a $1.4 million decrease in fair value for one award classified as a liability award, in accordance with ASC 718.
Stock-Based Compensation
The following tables summarize the effects of stock-based compensation on the Company’s condensed consolidated balance sheets and statements of operations for the periods presented (in thousands):
	27-Sep-14				28-Dec-13
Stock-based compensation effects in inventory	$	3,160			$	3,189
Stock-based compensation effects in deferred inventory cost	$	13			$	15
Stock-based compensation effects in fixed assets	$	126			$	145
	Three Months Ended								Nine Months Ended
	27-Sep-14				28-Sep-13				27-Sep-14		28-Sep-13
Stock-based compensation effects included in net income (loss) before income taxes
Cost of revenue	$	492			$	422			$	1,421	$	1,382
Research and development	2,270				2,434				6,488		8,175
Sales and marketing	1,982				1,853				5,517		5,659
General and administration	1,628				1,807				4,707		4,167
	6,372				6,516				18,133		19,383
Cost of revenue – amortization from balance sheet (1)	999				1,127				2,714		4,419
Total stock-based compensation expense	$	7,371			$	7,643			$	20,847	$	23,802
_________________
(1)	Stock-based compensation expense deferred to inventory and deferred inventory costs in prior periods and recognized in the current period.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 27, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	Provision for income taxes for the three and nine months ended September 27, 2014 was $0.2 million and $1.1 million, respectively, on pre-tax income of $5.0 million and $6.3 million, respectively. This compared to a tax provision of $0.3 million and $1.2 million, respectively, on pre-tax income of $3.7 million and a pre-tax loss of $20.7 million, respectively, for the three and nine months ended September 28, 2013. In all periods, the tax expense primarily represents foreign taxes of the Company's overseas subsidiaries compensated on a cost plus basis and remains relatively similar in all periods, regardless of the level of consolidated earnings. Because of the Company's significant loss carryforward position and corresponding full valuation allowance, the Company has not been subject to federal or state tax on its U.S. income because of the availability of loss carryforwards, with the exception of nominal amounts of state taxes for which the losses are limited by statute. The release of transfer pricing reserves in the future will have a beneficial impact to tax expense, but the timing of the impact depends on factors such as expiration of the statute of limitations or settlements with tax authorities. No significant releases are expected in the near future based on information available at this time.
	The Company regularly assesses the need for the valuation allowance on its deferred tax assets based on the technical accounting guidance available. Based upon that guidance and its historical operating losses, the Company believes that its deferred tax assets are not more-likely-than-not to be realized. Accordingly, the Company has provided a full valuation allowance against its domestic deferred tax assets, net of deferred tax liabilities, as of September 27, 2014 and December 28, 2013. In assessing this position, the Company will consider historical cumulative operating profits and losses, future market growth, forecasted earnings, future taxable income, the mix of earnings in the jurisdictions in which it operates, and prudent and feasible tax planning strategies in determining the need for a valuation allowance. To the extent that the Company determines that deferred tax assets are realizable on a more-likely-than-not basis and an adjustment is needed, that adjustment will be recorded in the period that the determination is made and would generally decrease the valuation allowance and record a corresponding benefit to earnings.

Segment_Information

Segment Information	9 Months Ended
	Sep. 27, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	Segment Information
	Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is the Company’s Chief Executive Officer ("CEO"). The Company’s CEO reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region for purposes of allocating resources and evaluating financial performance. The Company has one business activity. Accordingly, the Company is considered to be in a single reporting segment and operating unit structure.
	Revenue by geographic region is based on the shipping address of the customer. The following tables set forth revenue and long-lived assets by geographic region (in thousands):
	Revenue
		Three Months Ended				Nine Months Ended
		27-Sep-14		28-Sep-13		27-Sep-14		28-Sep-13
	Americas:
	United States	$	120,769	$	103,113	$	367,802	$	270,437
	Other Americas	9,230		2,024		17,526		6,544
		129,999		105,137		385,328		276,981
	Europe, Middle East and Africa	34,131		32,262		78,978		103,022
	Asia Pacific and Japan	9,429		4,621		17,467		25,027
	Total revenue	$	173,559	$	142,020	$	481,773	$	405,030
	Property, plant and equipment, net
		27-Sep-14		December 28,
				2013
	United States	$	72,428	$	76,850
	Other Americas	237		319
	Europe, Middle East and Africa	943		1,451
	Asia Pacific and Japan	1,356		1,048
	Total property, plant and equipment, net	$	74,964	$	79,668

Guarantees

Guarantees	9 Months Ended
	Sep. 27, 2014
Guarantees [Abstract]	'
Guarantees	'
	Guarantees
	Product Warranties
	Upon delivery of products, the Company provides for the estimated cost to repair or replace products including the related components that may be returned under hardware warranties. In general, hardware warranty periods range from one to five years. Hardware warranties provide the purchaser with protection in the event that the product does not perform to product specifications. During the warranty period, the purchaser’s sole and exclusive remedy in the event of such defect or failure to perform is limited to the correction of the defect or failure by repair or replacement. The Company estimates its hardware warranty obligations based on the Company’s historical experience of known product failure rates, use of materials and labor to repair or replace defective products, and service delivery costs incurred in correcting product failures. In addition, from time to time, specific hardware warranty accruals may be made if unforeseen technical problems arise with specific products. Management periodically assesses the adequacy of the Company’s recorded warranty liabilities and adjusts the amounts as necessary.
	Activity related to product warranty was as follows (in thousands):
		Three Months Ended						Nine Months Ended
		27-Sep-14			28-Sep-13			27-Sep-14			28-Sep-13
	Beginning balance	$	27,948		$	19,701		$	22,908		$	16,482
	Charges to operations	5,820			5,220			18,181			16,646
	Utilization	(2,312		)	(2,645		)	(7,924		)	(6,783		)
	Change in estimate (1)	(3,650		)	886			(5,359		)	(3,183		)
	Balance at the end of the period	$	27,806		$	23,162		$	27,806		$	23,162
	_________________
	(1)	The Company records hardware warranty liabilities based on the latest quality and cost information available as of that date. The changes in estimate shown here are due to changes in overall actual failure rates and the resulting impact of these changes on the Company’s estimate of expected future returns, as well as changes in the estimated cost and the mix of new versus used units related to replacement of failed units.

Litigation_and_Contingencies

Litigation and Contingencies	9 Months Ended
	Sep. 27, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Litigation and Contingencies	'
	Litigation and Contingencies
	Legal Matters
	From time to time, the Company is subject to various legal proceedings, claims and litigation arising in the ordinary course of business. While the outcome of these matters is currently not determinable, the Company does not expect that the ultimate costs to resolve these matters will have a material effect on its consolidated financial position, results of operations, or cash flows.
	Cambrian Science Patent Infringement Litigation
	On July 12, 2011, the Company was notified by Level 3 that Cambrian Science Corporation ("Cambrian") filed suit against Level 3 and six other defendants, including Cox Communications, Inc., XO Communications, LLC, Global Crossing Limited, 360Networks (USA), Inc., Integra Telecom, Inc. and IXC, Inc. dba Telekenex (collectively, the "Defendants") in the U.S. District Court for the Central District of California alleging infringement of patent no. 6,775,312 (the "'312 Patent") and requesting damages for such alleged infringement (the "Cambrian Claim"). The nature of the Cambrian Claim involves allegations of infringement of the '312 Patent resulting from the Defendants’ use of certain products and systems in the Defendants’ networks, including our DTN platform. On August 24, 2011, Cambrian amended the complaint to name the Company as a defendant. The Company assumed the defense of the Cambrian Claim and filed an answer to Cambrian’s complaint on September 21, 2011, in which the Company denied infringement of the '312 Patent and raised other defenses. Cambrian filed a second amended complaint on October 6, 2011, which included many of the same allegations as in the original complaint. The Company filed its answer to the second amended complaint on October 21, 2011, in which the Company maintained the same denials and defenses as in the Company’s initial answer. On December 23, 2011, the Company filed a motion requesting that the court stay the case with respect to each of the above-noted customer Defendants. Cambrian filed its opposition to the Company’s motion on December 30, 2011. The Company’s request was denied in the court’s decision on March 7, 2012. The Company presented evidence on the appropriate meanings of relevant key words used in the patent claims during a claim construction hearing on November 20, 2012.
	On June 17, 2013, the court issued an order regarding claim construction, in which the court agreed with almost all of the Company’s proposed claim constructions. On October 17, 2013, the parties met for a court-mandated mediation. On April 24, 2014, the Company filed two motions for summary judgment relating to non-infringement and Cambrian’s claim to an earlier date of invention. The court held a hearing on the summary judgment motions on June 9, 2014. On July 2, 2014, the court granted the Company's motion for summary judgment on non-infringement and entered a final judgment of non-infringement of the '312 Patent. On August 1, 2014, Cambrian filed a notice of appeal regarding the ruling of non-infringement to the Court of Appeals for the Federal Circuit. The Company is seeking to recover certain costs and attorney's fees from Cambrian.
	Based on the information available at this time, the Company has concluded that the likelihood of a loss with respect to this suit is reasonably possible. The Company has further concluded that the range of the reasonably possible loss is an insignificant amount and will not have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. Accordingly, the Company has accrued an insignificant amount, which did not have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. Factors that the Company considered in the determination of the likelihood of a loss and the estimate of that loss in respect to this matter included the merits of the case, the nature of the litigation (including the complex and technical nature of patent litigation), the length of time the matter has been pending, the status of the plaintiff as a non-operating entity and the likelihood of the plaintiff accepting the estimated amount. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties.
	Loss Contingencies
	The Company is subject to the possibility of various losses arising in the ordinary course of business. These may relate to disputes, litigation and other legal actions. In the preparation of its quarterly and annual financial statements, the Company considers the likelihood of loss or the incurrence of a liability, including whether it is probable, reasonably possible or remote that a liability has been incurred, as well as the Company’s ability to reasonably estimate the amount of loss, in determining loss contingencies. In accordance with U.S. GAAP, an estimated loss contingency is accrued when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information to determine whether any accruals should be adjusted and whether new accruals are required. As of September 27, 2014, the Company has not accrued or recorded any such material liabilities other than for the accrual associated with the Cambrian lawsuit.

Recent_Accounting_Pronouncemen1

Recent Accounting Pronouncements Recent Accounting Pronouncements (Policies)	9 Months Ended
	Sep. 27, 2014
Accounting Changes and Error Corrections [Abstract]	'
Income tax	'
	The Company's adoption of ASU 2013-11 during the first quarter of 2014 had no impact on the Company’s financial position, results of operations or cash flow.

Fair_Value_Measurements_and_Ot1

Fair Value Measurements and Other-Than-Temporary Impairments (Tables)	9 Months Ended
	Sep. 27, 2014
Fair Value Disclosures [Abstract]	'
Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	The following tables represent the Company’s fair value hierarchy for its assets and liabilities measured at fair value on a recurring basis (in thousands):
		As of September 27, 2014														As of December 28, 2013
		Fair Value Measured Using														Fair Value Measured Using
		Level 1			Level 2			Level 3				Total				Level 1				Level 2		Level 3		Total
	Assets
	Money market funds	$	15,369		$	—		$	—			$	15,369			$	51,749			$	—	$	—	$	51,749
	Certificates of deposit	—			3,460			—				3,460				—				3,840		—		3,840
	Commercial paper	—			83,838			—				83,838				—				85,860		—		85,860
	Corporate bonds	—			202,804			—				202,804				—				150,595		—		150,595
	U.S. treasuries	8,833			—			—				8,833				4,804				—		—		4,804
	Foreign currency exchange forward contracts	—			—			—				—				—				29		—		29
	Total assets	$	24,202		$	290,102		$	—			$	314,304			$	56,553			$	240,324	$	—	$	296,877
	Liabilities
	Foreign currency exchange forward contracts	$	—		$	32		$	—			$	32			$	—			$	26	$	—	$	26
Investments at Fair Value	'
	Investments at fair value were as follows (in thousands):
		27-Sep-14
		Adjusted Amortized Cost			Gross Unrealized Gains			Gross Unrealized				Fair Value
								Losses
	Money market funds	$	15,369		$	—		$	—			$	15,369
	Certificates of deposit	3,460			—			—				3,460
	Commercial paper	83,838			2			(2		)		83,838
	Corporate bonds	202,959			19			(174		)		202,804
	U.S. treasuries	8,829			5			(1		)		8,833
	Total available-for-sale investments	$	314,455		$	26		$	(177	)		$	314,304
		December 28, 2013
		Adjusted Amortized Cost			Gross Unrealized Gains			Gross Unrealized Losses				Fair Value
	Money market funds	$	51,749		$	—		$	—			$	51,749
	Certificates of deposit	3,840			—			—				3,840
	Commercial paper	85,870			2			(12		)		85,860
	Corporate bonds	150,711			27			(143		)		150,595
	U.S. treasuries	4,802			2			—				4,804
	Total available-for-sale investments	$	296,972		$	31		$	(155	)		$	296,848
Schedule of Amortized Cost Cumulative Other Than Temporary Impairment Recognized in Earnings and Accumulated Other Comprehensive Loss	'
	A roll-forward of amortized cost, cumulative other-than-temporary impairments ("OTTI") recognized in earnings and accumulated other comprehensive loss for the nine months ended September 28, 2013 were as follows (in thousands):
		Amortized			Cumulative				Unrealized				OTTI Loss in				Accumulated
		Cost			OTTI in				Gain				Accumulated				Other
					Earnings								Other				Comprehensive
													Comprehensive				Income (Loss)
													Loss
	Balance at December 29, 2012	$	2,707		$	(394	)		$	784			$	(618	)		$	166
	Call on investments	(87		)	13				(25		)		20				(5		)
	Investments sold	(2,620		)	381				(759		)		598				(161		)
	Balance at September 28, 2013	$	—		$	—			$	—			$	—			$	—

Derivative_Instruments_Tables

Derivative Instruments (Tables)	9 Months Ended
	Sep. 27, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Fair Value of Derivative Instruments not Designated as Hedging Instruments	'
	The fair value of derivative instruments not designated as hedging instruments in the Company’s condensed consolidated balance sheets was as follows (in thousands):
		As of September 27, 2014							As of December 28, 2013
		Gross Notional(1)		Prepaid Expenses and Other Assets		Other			Gross Notional(1)		Prepaid Expenses and Other Assets		Other
						Accrued							Accrued
						Liabilities							Liabilities
	Foreign currency exchange forward contracts
	Related to euro denominated receivables	$	20,980	—		$	(30	)	$	16,867	27		$	—
	Related to British pound denominated receivables	165		—		—			13,271		—		(26		)
	Related to restricted cash	1,287		—		(2		)	1,391		2		—
		$	22,432	$	—	$	(32	)	$	31,529	$	29	$	(26	)
	_________________
	(1)	Represents the face amounts of forward contracts that were outstanding as of the period noted.

Balance_Sheet_Details_Tables

Balance Sheet Details (Tables)	9 Months Ended
	Sep. 27, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Details of Selected Balance Sheet Items	'
	The following table provides details of selected balance sheet items (in thousands):
		27-Sep-14			28-Dec-13
	Inventory:
	Raw materials	$	11,584		$	14,311
	Work in process	44,462			49,172
	Finished goods (1)	74,787			60,202
	Total inventory	$	130,833		$	123,685
	Property, plant and equipment, net:
	Computer hardware	$	8,515		$	9,692
	Computer software(2)	17,679			16,988
	Laboratory and manufacturing equipment	158,446			146,834
	Furniture and fixtures	1,343			1,347
	Leasehold improvements	37,258			35,913
	Construction in progress	6,465			8,950
	Subtotal	$	229,706		$	219,724
	Less accumulated depreciation and amortization	(154,742		)	(140,056		)
	Total property, plant and equipment, net	$	74,964		$	79,668
	Accrued expenses:
	Loss contingency related to non-cancelable purchase commitments	$	6,242		$	5,120
	Professional and other consulting fees	1,033			1,411
	Taxes payable	1,620			2,372
	Royalties	2,152			1,540
	Accrued rebate and customer prepay liability	758			3,807
	Accrued interest on convertible senior notes	875			219
	Other accrued expenses	10,913			7,962
	Total accrued expenses	$	23,593		$	22,431
	_________________
	(1)	Included in finished goods inventory at September 27, 2014 and December 28, 2013 were $16.2 million and $9.2 million, respectively, of inventory at customer locations for which product acceptance had not occurred.
	(2)	Included in computer software at September 27, 2014 and December 28, 2013 were $7.9 million and $7.9 million, respectively, related to an enterprise resource planning ("ERP") system that the Company implemented during 2012. The unamortized ERP costs at September 27, 2014 and December 28, 2013 were $5.4 million and $6.3 million, respectively.
Schedule of Components of Restricted Cash	'
	The following table sets forth the Company's restricted cash (in thousands):
		27-Sep-14			28-Dec-13
	Restricted cash related to outstanding standby letters of credit
	Value added tax license	$	1,362		$	1,430
	Customer proposal guarantee	1,771			1,446
	Property leases	699			699
	Other	392			329
	Total restricted cash	$	4,224		$	3,904

Accumulated_Comprehensive_Loss1

Accumulated Comprehensive Loss (Tables)	9 Months Ended
	Sep. 27, 2014
Equity [Abstract]	'
Summary of Changes in Accumulated Other Comprehensive Income (Loss)	'
	Other comprehensive loss includes certain changes in equity that are excluded from net income (loss). The following table sets forth the changes in accumulated other comprehensive loss by component for the nine months ended September 27, 2014 (in thousands):
		Unrealized Gain			Foreign			Accumulated			Total
		on Other			Currency Translation			Tax Effect
		Available-for-Sale
		Securities
	Balance at December 28, 2013	$	(124	)	$	(2,602	)	$	(760	)	$	(3,486	)
	Net current-period other comprehensive loss	(27		)	(142		)	—			(169		)
	Balance at September 27, 2014	$	(151	)	$	(2,744	)	$	(760	)	$	(3,655	)

Basic_and_Diluted_Net_Income_L1

Basic and Diluted Net Income (Loss) Per Common Share (Tables)	9 Months Ended
	Sep. 27, 2014
Earnings Per Share [Abstract]	'
Computation of Net Income (Loss) Per Common Share Basic and Diluted	'
	The following table sets forth the computation of net income (loss) per common share – basic and diluted (in thousands, except per share amounts):
		Three Months Ended						Nine Months Ended
		27-Sep-14			28-Sep-13			27-Sep-14		28-Sep-13
	Numerator:
	Net income (loss)	$	4,843		$	3,347		$	5,249	$	(21,941	)
	Denominator:
	Basic weighted average common shares outstanding	124,378			118,740			122,953		116,653
	Effect of dilutive securities:
	Employee equity plans	4,586			5,939			4,109		—
	Diluted weighted average common shares outstanding	128,964			124,679			127,062		116,653
	Net income (loss) per common share
	Basic	$	0.04		$	0.03		$0.04		$	(0.19	)
	Diluted	$	0.04		$	0.03		$0.04		$	(0.19	)
Antidilutive Shares Excluded from Computation of Diluted Net Income (Loss) Per Share	'
	The effects of these potentially outstanding shares were not included in the calculation of diluted net income (loss) per share because their effect would have been anti-dilutive under the treasury stock method or the performance condition of the award has not been met (in thousands):
		Three Months Ended					Nine Months Ended
		27-Sep-14		28-Sep-13			27-Sep-14		28-Sep-13
	Stock options	447		408			706		6,603
	Restricted stock units	68		89			250		6,559
	Performance stock units	185		211			185		721
	Employee stock purchase plan shares	801		675			921		675
	Total	1,501		1,383			2,062		14,558

Convertible_Senior_Notes_Table

Convertible Senior Notes (Tables)	9 Months Ended
	Sep. 27, 2014
Debt Disclosure [Abstract]	'
Components of Convertible Senior Notes	'
	The amounts recorded in connection with the issuance of the Notes and related amortization consisted of the following (in thousands):
		Other Non-Current Assets			Long-Term Debt			Additional Paid-in Capital
	Principal amount	$	—		$	150,000		$	—
	Debt discount	—			(45,000		)	—
	Equity component	—			—			45,000
	Debt issuance cost	3,872			—			(1,659		)
	Initial transaction amounts	$	3,872		$	105,000		$	43,341
	Amortization of debt issuance cost	(851		)	—			—
	Amortization of debt discount	—			9,888			—
	Net carrying amount at September 27, 2014	$	3,021		$	114,888		$	43,341
Interest Expense Recognized Related to Notes	'
	The following table sets forth total interest expense recognized related to the Notes (in thousands):
		Three Months Ended						Nine Months Ended
		27-Sep-14			28-Sep-13			27-Sep-14			28-Sep-13
	Contractual interest expense	$	656		$	656		$	1,969		$	875
	Amortization of debt issuance costs	169			152			493			202
	Amortization of debt discount	1,956			1,770			5,724			2,350
	Total interest expense	$	2,781		$	2,578		$	8,186		$	3,427

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 27, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Summary of Company's Equity Award Activity - Options	'
	The following tables summarize the Company’s equity award activity and related information (in thousands, except per share data):
		Number of Stock			Weighted-Average				Aggregate
		Options			Exercise				Intrinsic
					Price				Value
					Per Share
	Outstanding at December 28, 2013	6,367			$	7.26			$	17,452
	Stock options granted	25			$	9.02
	Stock options exercised	(1,280	)		$	6.99			$	3,210
	Stock options canceled	(92	)		$	12.39
	Outstanding at September 27, 2014	5,020			$	7.24			$	17,631
	Vested and expected to vest as of September 27, 2014	5,017							$	17,622
	Exercisable at September 27, 2014	4,921			$	7.24			$	17,329
Summary of Company's Equity Award Activity - RSUs	'
		Number of			Weighted-				Aggregate
		Restricted			Average				Intrinsic
		Stock Units			Grant Date				Value
					Fair Value
					Per Share
	Outstanding at December 28, 2013	6,583			$	7.72			$	64,443
	RSUs granted	2,415			$	8.37
	RSUs released	(2,625	)		$	7.74			$	22,477
	RSUs canceled	(424	)		$	7.88
	Outstanding at September 27, 2014	5,949			$	7.97			$	63,122
	Expected to vest at September 27, 2014	5,751							$	61,021
Summary of Company's Equity Award Activity - PSUs	'
		Number of			Weighted-				Aggregate
		Performance			Average				Intrinsic
		Stock Units			Grant Date				Value
					Fair Value
					Per Share
	Outstanding at December 28, 2013	721			$	7.04			$	7,054
	PSUs granted	508			$	7.53
	PSUs released	(255	)		$	6.36			$	2,097
	PSUs canceled	(97	)		$	7.18
	Outstanding at September 27, 2014	877			$	7.49			$	9,298
	Expected to vest at September 27, 2014	659							$	6,994
Total Stock Based Compensation Cost for Instruments Granted but Not Yet Amortized	'
	The following table presents total stock-based compensation cost for instruments granted but not yet amortized, net of estimated forfeitures, of the Company’s equity compensation plans as of September 27, 2014. These costs are expected to be amortized on a straight-line basis over the following weighted-average periods (in thousands, except for weighted-average period):
		Unrecognized			Weighted-
		Compensation			Average Period
		Expense, Net			(in years)
	Stock options	317			1.5
	RSUs	30,599			2.3
	PSUs	2,704			1.6
Ranges of Estimated Values of Stock Options and Performance-Based Stock Options Granted	'
	The estimated values of stock options, as well as assumptions used in calculating these values were based on estimates as follows (expense amounts in thousands):
		Three Months Ended				Nine Months Ended
	Employee and Director Stock Options	27-Sep-14		28-Sep-13		27-Sep-14		28-Sep-13
	Volatility	N/A		N/A		52%		N/A
	Risk-free interest rate	N/A		N/A		1.30%		N/A
	Expected life	N/A		N/A		4.3 years		N/A
	Estimated fair value	N/A		N/A		$3.85		N/A
	Total stock-based compensation expense	$108		$665		$623		$2,190
	_________________
	N/A	Not applicable because the Company did not grant any stock options to employees for the periods presented.
Estimated Fair Value of ESPP Shares	'
	The fair value of the ESPP shares was estimated at the date of grant using the following assumptions (expense amounts in thousands):
		Three Months Ended				Nine Months Ended
	Employee Stock Purchase Plan	27-Sep-14		28-Sep-13		27-Sep-14		28-Sep-13
	Volatility	46%		49%		46% - 51%		46% - 49%
	Risk-free interest rate	0.06%		0.10%		0.02% - 0.11%		0.10% - 0.14%
	Expected life	0.5 years		0.5 years		0.25 - 0.5 years		0.5 years
	Estimated fair value	$2.54		$3.00		$2.05 - $2.57		$1.87 - $3.00
	Total stock-based compensation expense	$1,092		$777		$2,726		$2,050
Schedule of Share-based Payment Award, Valuation Assumptions	'
	The ranges of estimated values of the PSUs granted, as well as assumptions used in calculating these values were based on estimates as follows:
		Year Ended
		28-Dec-13
	Infinera Volatility	55%
	NASDAQ Telecom Composite Index Volatility	23%
	Risk-free interest rate	0.42%
	Correlation with NASDAQ Telecom Composite Index	0.56
	Estimated fair value	$6.27 - $7.06
Schedule of Additional Share-based Payment Award, Valuation Assumptions	'
	The ranges of estimated values of the PSUs granted, as well as assumptions used in calculating these values were based on estimates as follows:
			Nine Months Ended
			27-Sep-14
	Infinera Volatility		49% - 50%
	IGN Index Volatility		25%
	Risk-free interest rate		0.66% - 0.71%
	Correlation with IGN Index		0.6
	Estimated fair value		$6.59 - $7.60
Summary of Effects of Stock-Based Compensation on Company's Balance Sheets and Statements of Operations	'
	The following tables summarize the effects of stock-based compensation on the Company’s condensed consolidated balance sheets and statements of operations for the periods presented (in thousands):
		27-Sep-14				28-Dec-13
	Stock-based compensation effects in inventory	$	3,160			$	3,189
	Stock-based compensation effects in deferred inventory cost	$	13			$	15
	Stock-based compensation effects in fixed assets	$	126			$	145
		Three Months Ended								Nine Months Ended
		27-Sep-14				28-Sep-13				27-Sep-14		28-Sep-13
	Stock-based compensation effects included in net income (loss) before income taxes
	Cost of revenue	$	492			$	422			$	1,421	$	1,382
	Research and development	2,270				2,434				6,488		8,175
	Sales and marketing	1,982				1,853				5,517		5,659
	General and administration	1,628				1,807				4,707		4,167
		6,372				6,516				18,133		19,383
	Cost of revenue – amortization from balance sheet (1)	999				1,127				2,714		4,419
	Total stock-based compensation expense	$	7,371			$	7,643			$	20,847	$	23,802
	_________________
	(1)	Stock-based compensation expense deferred to inventory and deferred inventory costs in prior periods and recognized in the current period.

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 27, 2014
Segment Reporting [Abstract]	'
Revenue and Long-Lived Assets by Geographic Region	'
	Revenue by geographic region is based on the shipping address of the customer. The following tables set forth revenue and long-lived assets by geographic region (in thousands):
	Revenue
		Three Months Ended				Nine Months Ended
		27-Sep-14		28-Sep-13		27-Sep-14		28-Sep-13
	Americas:
	United States	$	120,769	$	103,113	$	367,802	$	270,437
	Other Americas	9,230		2,024		17,526		6,544
		129,999		105,137		385,328		276,981
	Europe, Middle East and Africa	34,131		32,262		78,978		103,022
	Asia Pacific and Japan	9,429		4,621		17,467		25,027
	Total revenue	$	173,559	$	142,020	$	481,773	$	405,030
Property, Plant and Equipment, Net	'
	Property, plant and equipment, net
		27-Sep-14		December 28,
				2013
	United States	$	72,428	$	76,850
	Other Americas	237		319
	Europe, Middle East and Africa	943		1,451
	Asia Pacific and Japan	1,356		1,048
	Total property, plant and equipment, net	$	74,964	$	79,668

Guarantees_Tables

Guarantees (Tables)	9 Months Ended
	Sep. 27, 2014
Guarantees [Abstract]	'
Activity Related to Product Warranty	'
	Activity related to product warranty was as follows (in thousands):
		Three Months Ended						Nine Months Ended
		27-Sep-14			28-Sep-13			27-Sep-14			28-Sep-13
	Beginning balance	$	27,948		$	19,701		$	22,908		$	16,482
	Charges to operations	5,820			5,220			18,181			16,646
	Utilization	(2,312		)	(2,645		)	(7,924		)	(6,783		)
	Change in estimate (1)	(3,650		)	886			(5,359		)	(3,183		)
	Balance at the end of the period	$	27,806		$	23,162		$	27,806		$	23,162
	_________________
	(1)	The Company records hardware warranty liabilities based on the latest quality and cost information available as of that date. The changes in estimate shown here are due to changes in overall actual failure rates and the resulting impact of these changes on the Company’s estimate of expected future returns, as well as changes in the estimated cost and the mix of new versus used units related to replacement of failed units.

Fair_Value_Measurements_and_Ot2

Fair Value Measurements and Other-Than-Temporary Impairments - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2013	Mar. 30, 2013	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013
Fair Value Disclosures [Abstract]	'	'	'	'	'
Available-for-sale investments	'	'	'18 months	'	'
Available-for-sale Securities, Gross Realized Gain (Loss)	$0	'	'	$0.20	'
Cash	'	'	59.2	'	64.6
Disposal of auction rate securities par value	'	3.1	'	'	'
Realized gain on calls	'	$0.20	'	'	'

Fair_Value_Measurements_and_Ot3

Fair Value Measurements and Other-Than-Temporary Impairments - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Assets	'	'
Total Assets	$314,304	$296,877
Money Market Funds [Member]	'	'
Assets	'	'
Total Assets	15,369	51,749
Certificates of Deposit [Member]	'	'
Assets	'	'
Total Assets	3,460	3,840
Commercial Paper [Member]	'	'
Assets	'	'
Total Assets	83,838	85,860
Corporate Bonds [Member]	'	'
Assets	'	'
Total Assets	202,804	150,595
U.S. Treasuries [Member]	'	'
Assets	'	'
Total Assets	8,833	4,804
Foreign Currency Exchange Forward Contracts [Member]	'	'
Assets	'	'
Total Assets	0	29
Liabilities	'	'
Total Liabilities	32	26
Level 1 [Member]	'	'
Assets	'	'
Total Assets	24,202	56,553
Level 1 [Member] | Money Market Funds [Member]	'	'
Assets	'	'
Total Assets	15,369	51,749
Level 1 [Member] | Certificates of Deposit [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 1 [Member] | Commercial Paper [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 1 [Member] | Corporate Bonds [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 1 [Member] | U.S. Treasuries [Member]	'	'
Assets	'	'
Total Assets	8,833	4,804
Level 1 [Member] | Foreign Currency Exchange Forward Contracts [Member]	'	'
Assets	'	'
Total Assets	0	0
Liabilities	'	'
Total Liabilities	0	0
Level 2 [Member]	'	'
Assets	'	'
Total Assets	290,102	240,324
Level 2 [Member] | Money Market Funds [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 2 [Member] | Certificates of Deposit [Member]	'	'
Assets	'	'
Total Assets	3,460	3,840
Level 2 [Member] | Commercial Paper [Member]	'	'
Assets	'	'
Total Assets	83,838	85,860
Level 2 [Member] | Corporate Bonds [Member]	'	'
Assets	'	'
Total Assets	202,804	150,595
Level 2 [Member] | U.S. Treasuries [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 2 [Member] | Foreign Currency Exchange Forward Contracts [Member]	'	'
Assets	'	'
Total Assets	0	29
Liabilities	'	'
Total Liabilities	32	26
Level 3 [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 3 [Member] | Money Market Funds [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 3 [Member] | Certificates of Deposit [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 3 [Member] | Commercial Paper [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 3 [Member] | Corporate Bonds [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 3 [Member] | U.S. Treasuries [Member]	'	'
Assets	'	'
Total Assets	0	0
Level 3 [Member] | Foreign Currency Exchange Forward Contracts [Member]	'	'
Assets	'	'
Total Assets	0	0
Liabilities	'	'
Total Liabilities	$0	$0

Fair_Value_Measurements_and_Ot4

Fair Value Measurements and Other-Than-Temporary Impairments - Investments at Fair Value (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Adjusted Amortized Cost	$314,455	$296,972
Gross Unrealized Gains	26	31
Gross Unrealized Losses	-177	-155
Fair Value	314,304	296,848
Money Market Funds [Member]	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Adjusted Amortized Cost	15,369	51,749
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	15,369	51,749
Certificates of Deposit [Member]	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Adjusted Amortized Cost	3,460	3,840
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	3,460	3,840
Commercial Paper [Member]	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Adjusted Amortized Cost	83,838	85,870
Gross Unrealized Gains	2	2
Gross Unrealized Losses	-2	-12
Fair Value	83,838	85,860
Corporate Bonds [Member]	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Adjusted Amortized Cost	202,959	150,711
Gross Unrealized Gains	19	27
Gross Unrealized Losses	-174	-143
Fair Value	202,804	150,595
U.S. Treasuries [Member]	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Adjusted Amortized Cost	8,829	4,802
Gross Unrealized Gains	5	2
Gross Unrealized Losses	-1	0
Fair Value	$8,833	$4,804

Fair_Value_Measurements_and_Ot5

Fair Value Measurements and Other-Than-Temporary Impairments - Roll-Forward of Amortized Cost, Cumulative OTTI Recognized in Earnings and Accumulated Other Comprehensive Loss (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013	Sep. 28, 2013
In Thousands, unless otherwise specified			OTTI Recognized in Earnings and Accumulated Other Comprehensive Loss [Member]
Amortized Cost	'	'	'
Amortized Cost, Beginning balance	$314,455	$296,972	$2,707
Amortized Cost, Call on investments	'	'	-87
Amortized Cost, Investments sold	'	'	-2,620
Amortized Cost, Ending balance	314,455	296,972	0
Cumulative OTTI in Earnings	'	'	'
Cumulative OTTI in Earnings, Beginning balance	'	'	-394
Cumulative OTTI in Earnings, Call on investments	'	'	13
Cumulative OTTI in Earnings, Investments sold	'	'	381
Cumulative OTTI in Earnings, Ending balance	'	'	0
Unrealized Gain	'	'	'
Unrealized Gain, Beginning balance	'	'	784
Unrealized Gain, Call on investments	'	'	-25
Unrealized Gain, Investments Sold	'	'	-759
Unrealized Gain, Ending balance	'	'	0
OTTI Loss in Accumulated Other Comprehensive Loss	'	'	'
OTTI Loss in Accumulated Other Comprehensive Loss, Beginning balance	'	'	-618
OTTI Loss in Accumulated Other Comprehensive Loss, Call on investments	'	'	20
OTTI Loss in Accumulated Other Comprehensive Loss, Investments sold	'	'	598
OTTI Loss in Accumulated Other Comprehensive Loss, Ending balance	'	'	0
Accumulated Other Comprehensive Income (Loss)	'	'	'
Accumulated Other Comprehensive Income (Loss), Beginning balance	'	'	166
Accumulated Other Comprehensive Income (Loss), Call on investments	'	'	-5
Accumulated Other Comprehensive Income (Loss), Investments sold	'	'	-161
Accumulated Other Comprehensive Income (Loss), Ending balance	'	'	$0

Costmethod_Investment_Addition

Cost-method Investment - Additional Information (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 27, 2014	Sep. 28, 2013	Dec. 28, 2013
Investments, All Other Investments [Abstract]	'	'	'	'
Payments to Acquire Investments	$5,500	$5,500	$0	'
Cost-method investment	$14,500	$14,500	'	$9,000
Less than percent of voting securities	'	20.00%	'	'

Derivative_Instruments_Additio

Derivative Instruments - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'	'	'
British pound denominated receivables and typically maturities period	'35 days	'	'35 days	'
Euro denominated forward contracts maturity period	'35 days	'	'35 days	'
Before-tax effect of foreign currency exchange forward contracts not designated as hedging instruments, gain (loss)	$1.20	($1.20)	$0.80	($1.40)

Derivative_Instruments_Fair_Va

Derivative Instruments - Fair Value of Derivative Instruments Not Designated as Hedging Activities (Details) (USD $)	Sep. 27, 2014		Dec. 28, 2013
In Thousands, unless otherwise specified
Derivative [Line Items]	'		'
Gross Notional	$22,432	[1]	$31,529	[1]
Prepaid Expenses and Other Assets	21,714		17,752
Other Accrued Liabilities	-32		-26
Designated as Hedging Instrument [Member]	'		'
Derivative [Line Items]	'		'
Prepaid Expenses and Other Assets	0		29
Designated as Hedging Instrument [Member] | Euro Denominated Exchange Forward Contracts Receivables [Member]	'		'
Derivative [Line Items]	'		'
Gross Notional	20,980	[1]	16,867	[1]
Prepaid Expenses and Other Assets	0		27
Other Accrued Liabilities	-30		0
Designated as Hedging Instrument [Member] | GBP Denominated Exchange Forward Contracts Receivables [Member]	'		'
Derivative [Line Items]	'		'
Gross Notional	165	[1]	13,271	[1]
Prepaid Expenses and Other Assets	0		0
Other Accrued Liabilities	0		-26
Designated as Hedging Instrument [Member] | Foreign Currency Exchange Restricted Cash Forward Contracts [Member]	'		'
Derivative [Line Items]	'		'
Gross Notional	1,287	[1]	1,391	[1]
Prepaid Expenses and Other Assets	0		2
Other Accrued Liabilities	($2)		$0
[1]	Represents the face amounts of forward contracts that were outstanding as of the period noted.

Balance_Sheet_Details_Selected

Balance Sheet Details - Selected Balance Sheet Items (Details) (USD $)	Sep. 27, 2014		Dec. 28, 2013
Inventory:	'		'
Raw materials	$11,584,000		$14,311,000
Work in process	44,462,000		49,172,000
Finished goods	74,787,000	[1]	60,202,000	[1]
Total inventory	130,833,000		123,685,000
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	229,706,000		219,724,000
Less accumulated depreciation and amortization	-154,742,000		-140,056,000
Total property, plant and equipment, net	74,964,000		79,668,000
Accrued expenses:	'		'
Loss contingency related to non-cancelable purchase commitments	6,242,000		5,120,000
Professional and other consulting fees	1,033,000		1,411,000
Taxes payable	1,620,000		2,372,000
Royalties	2,152,000		1,540,000
Accrued rebate and customer prepay liability	758,000		3,807,000
Accrued interest on convertible senior notes	875,000		219,000
Other accrued expenses	10,913,000		7,962,000
Total accrued expenses	23,593,000		22,431,000
Enterprise Resource Planning Systems [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	7,900,000		7,900,000
Total property, plant and equipment, net	5,400,000		6,300,000
Computer Hardware [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	8,515,000		9,692,000
Computer Software [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	17,679,000	[2]	16,988,000	[2]
Laboratory and Manufacturing Equipment [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	158,446,000		146,834,000
Furniture and Fixtures [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	1,343,000		1,347,000
Leasehold Improvements [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	37,258,000		35,913,000
Construction in Progress [Member]	'		'
Property, plant and equipment, net:	'		'
Property, plant and equipment, gross	6,465,000		8,950,000
Customer Locations [Member]	'		'
Accrued expenses:	'		'
Inventory Awaiting Customer Acceptance	$16,200,000		$9,200,000
[1]	Included in finished goods inventory at September 27, 2014 and December 28, 2013 were $16.2 million and $9.2 million, respectively, of inventory at customer locations for which product acceptance had not occurred.
[2]	Included in computer software at September 27, 2014 and December 28, 2013 were $7.9 million and $7.9 million, respectively, related to an enterprise resource planning ("ERP") system that the Company implemented during 2012. The unamortized ERP costs at September 27, 2014 and December 28, 2013 were $5.4 million and $6.3 million, respectively.

Balance_Sheet_Details_Restrict

Balance Sheet Details - Restricted Cash (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Value added tax license	$1,362	$1,430
Customer proposal guarantee	1,771	1,446
Property leases	699	699
Other restricted cash	392	329
Long-term restricted cash	$4,224	$3,904

Accumulated_Comprehensive_Loss2

Accumulated Comprehensive Loss - Summary of Changes in Accumulated Other Comprehensive Loss (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	'	'	($3,486)	'
Net change in accumulated other comprehensive loss	-543	-54	-169	-1,246
Ending balance	-3,655	'	-3,655	'
Unrealized Gain on Other Available-for-Sale Securities [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	'	'	-124	'
Net change in accumulated other comprehensive loss	'	'	-27	'
Ending balance	-151	'	-151	'
Foreign Currency Translation [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	'	'	-2,602	'
Net change in accumulated other comprehensive loss	'	'	-142	'
Ending balance	-2,744	'	-2,744	'
Accumulated Tax Effect [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	'	'	-760	'
Net change in accumulated other comprehensive loss	'	'	0	'
Ending balance	($760)	'	($760)	'

Basic_and_Diluted_Net_Income_L2

Basic and Diluted Net Income (Loss) Per Common Share Basic and Diluted Net Income (Loss) Per Common Share - Computation of Net Loss Per Common Share Basic and Diluted (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net income (loss)	$4,843	$3,347	$5,249	($21,941)
Basic weighted average common shares outstanding (in shares)	124,378	118,740	122,953	116,653
Employee equity plans (in shares)	4,586	5,939	4,109	0
Diluted weighted average common shares outstanding (in shares)	128,964	124,679	127,062	116,653
Net income (loss) per common share	'	'	'	'
Basic (USD per share)	$0.04	$0.03	$0.04	($0.19)
Diluted (USD per share)	$0.04	$0.03	$0.04	($0.19)

Basic_and_Diluted_Net_Income_L3

Basic and Diluted Net Income (Loss) Per Common Share Basic and Diluted Net Income (Loss) Per Common Share - Antidilutive Shares Excluded from Computation of Diluted Net Loss Per Share (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from earnings per share computation	1,501	1,383	2,062	14,558
Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from earnings per share computation	447	408	706	6,603
RSUs [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from earnings per share computation	68	89	250	6,559
PSUs [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from earnings per share computation	185	211	185	721
ESPP [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from earnings per share computation	801	675	921	675

Convertible_Senior_Notes_Addit

Convertible Senior Notes - Additional Information (Details) (USD $)	1 Months Ended	9 Months Ended				9 Months Ended	12 Months Ended
	31-May-13	Sep. 27, 2014	Sep. 28, 2013	Sep. 26, 2014	30-May-13	Sep. 27, 2014	Dec. 28, 2013	30-May-13
						1.75% Convertible Senior Notes Due June 1, 2018 [Member]	1.75% Convertible Senior Notes Due June 1, 2018 [Member]	1.75% Convertible Senior Notes Due June 1, 2018 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'	'	'	'	'	'
Debt instrument issued	'	'	'	'	'	'	'	$150,000,000
Debt instrument interest percentage	'	1.75%	'	'	'	'	'	1.75%
Proceeds from issuance of debt, net	'	0	144,469,000	'	'	'	144,469,000	'
Initial conversion rate per $1,000 principal amount of Notes	0.0794834	'	'	'	'	'	'	'
Initial conversion price	'	'	'	'	$12.58	'	'	'
Convertible threshold trading days	'20 days	'	'	'	'	'	'	'
Convertible threshold consecutive trading days	'30 days	'	'	'	'	'	'	'
Convertible threshold minimum percentage	130.00%	'	'	'	'	'	'	'
Debt instrument, convertible, if-converted value in excess of principal	1,000	'	'	'	'	'	'	'
Convertible, threshold maximum percentage	98.00%	'	'	'	'	'	'	'
Purchase price as a percentage on principal amount of the notes upon the occurrence of a fundamental change	100.00%	'	'	'	'	'	'	'
Debt instrument discount to be amortized	'	'	'	'	'	35,100,000	'	'
Debt issuance cost	'	'	'	'	'	5,500,000	'	'
Deferred tax liability	'	'	'	'	'	17,000,000	'	'
Additional effective rate of interest to be used on amortized carrying value	'	10.23%	'	'	'	'	'	'
Total estimated fair value of the notes	'	$167,300,000	'	'	'	'	'	'
Closing price of common stock (in usd per share)	'	'	'	$10.61	'	'	'	'

Convertible_Senior_Notes_Compo

Convertible Senior Notes - Components of Convertible Senior Notes (Details) (1.75% Convertible Senior Notes Due June 1, 2018 [Member], USD $)	30-May-13	Sep. 27, 2014	Sep. 27, 2014	Sep. 27, 2014
		Additional Paid-in Capital [Member]	Other Noncurrent Assets [Member]	Long-term Debt [Member]
Debt Instrument [Line Items]	'	'	'	'
Principal amount	$150,000,000	'	'	$150,000,000
Debt discount	'	'	'	-45,000,000
Equity component	'	45,000,000	'	'
Initial transaction amounts and debt issuance cost	'	'	3,872,000	'
Debt issuance cost	'	-1,659,000	'	'
Initial transaction amounts, long-term debt	'	'	'	105,000,000
Initial transaction amount and net carrying amount, APIC	'	43,341,000	'	'
Amortization of debt issuance cost	'	'	-851,000	'
Amortization of debt discount	'	'	'	9,888,000
Net carrying amount, other non-current assets	'	'	3,021,000	'
Net carrying amount, long-term debt	'	'	'	$114,888,000

Convertible_Senior_Notes_Inter

Convertible Senior Notes - Interest Expense Recognized Related to Notes Prior to Capitalization of Interest (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Debt Disclosure [Abstract]	'	'	'	'
Contractual interest expense	$656	$656	$1,969	$875
Amortization of debt issuance costs	169	152	493	202
Amortization of debt discount	1,956	1,770	5,724	2,350
Total interest expense recognized related to notes prior to capitalization of interest	$2,781	$2,578	$8,186	$3,427

Stockholders_Equity_Additional

Stockholders' Equity - Additional Information (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

In Millions, except Per Share data, unless otherwise specified

Sep. 27, 2014

Sep. 27, 2014

Sep. 26, 2014

Dec. 28, 2013

Sep. 27, 2014

Sep. 27, 2014

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Dec. 29, 2012

Dec. 28, 2013

Dec. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 27, 2014

NASDAQ Telecom Composite Index [Member]

IGN Index [Member]

IGN Index [Member]

Performance Stock Units Grants [Member]

Performance Stock Units Grants [Member]

Performance Stock Units Grants [Member]

Performance Stock Units Grants [Member]

Performance Stock Units Grants [Member]

PSUs [Member]

PSUs [Member]

Restricted Stock Units [Member]

Restricted Stock Units [Member]

Restricted Stock Units [Member]

Restricted Stock Units [Member]

2007 Equity Incentive Plan [Member]

2007 Equity Incentive Plan [Member]

Minimum [Member]

Maximum [Member]

NASDAQ Telecom Composite Index [Member]

NASDAQ Telecom Composite Index [Member]

Minimum [Member]

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Granted options to employees to purchase shares of common stock (in shares)

17.5

17.5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing price of common stock (in usd per share)

'

'

$10.61

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares available for grant cost (in shares)

0.1

2.4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of stock-based compensation

'

'

'

'

'

'

$0.60

$0.50

$1.50

$0.10

'

'

'

$5.60

$5.50

$15.90

$18.20

'

'

Shares of PSUs to executive officers (in shares)

'

'

'

0.6

0

0.4

0.1

'

'

'

0.5

'

'

'

'

'

'

'

'

Ranges of number of shares issued on vesting of PSUs

'

'

'

'

'

'

'

'

'

'

'

0

1.5

'

'

'

'

0

1.5

Amortization of stock based compensation expense offset

'

'

'

'

'

'

'

'

'

1.5

'

'

'

'

'

'

'

'

'

Decrease in fair value

'

'

'

'

'

'

'

'

'

$1.40

'

'

'

'

'

'

'

'

'

Stockholders_Equity_Summary_of

Stockholders' Equity - Summary of Company's Equity Award Activity - Options (Details) (Stock Options [Member], USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2014
Stock Options [Member]	'
Number of Stock Options	'
Number of Options, beginning balance (in shares)	6,367
Number of options, granted (in shares)	25
Number of Options, exercised (in shares)	-1,280
Number of Options, canceled (in shares)	-92
Number of Options, ending balance (in shares)	5,020
Number of Options, vested and expected to vest (in shares)	5,017
Number of Options, exercisable (in shares)	4,921
Weighted-Average Exercise Price Per Share	'
Weighted-Average Exercise Price Per Share, beginning balance (in usd per share)	$7.26
Weighted-Average Exercise Per Share, Options granted (in usd per share)	$9.02
Weighted-Average Exercise Price Per Share, Options exercised (in usd per share)	$6.99
Weighted-Average Exercise Price Per Share, Options canceled (in usd per share)	$12.39
Weighted-Average Exercise Price Per Share, ending balance (in usd per share)	$7.24
Average Exercise Price Per Share, Exercisable	$7.24
Aggregate Intrinsic Value	'
Aggregate Intrinsic Value, beginning balance	$17,452
Aggregate Intrinsic Value, Options exercised	3,210
Aggregate Intrinsic Value, ending balance	17,631
Aggregate Intrinsic Value, Vested and expected to vest	17,622
Aggregate Intrinsic Value, Exercisable	$17,329

Stockholders_Equity_Summary_of1

Stockholders' Equity - Summary of Company's Equity Award Activity - RSUs (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2014	Sep. 27, 2014
Restricted Stock Units [Member]	'	'
Number of Restricted Stock Units	'	'
Number of Restricted/Performance Stock Units, beginning balance (in shares)	'	6,583
Number of Restricted Stock Units, granted (in shares)	'	2,415
Number of Restricted Stock Units, released (in shares)	'	-2,625
Number of Restricted Stock Units, canceled (in shares)	'	-424
Number of Restricted/Performance Stock Units, ending balance (in shares)	5,949	5,949
Number of Restricted Stock Units, Expected to vest (in shares)	5,751	5,751
Weighted- Average Grant Date Fair Value Per Share	'	'
Weighted-Average Grant Date Fair Value Per Share, beginning balance (in usd per share)	'	7.72
Weighted-Average Grant Date Fair Value Per Share, granted (in usd per share)	'	8.37
Weighted-Average Grant Date Fair Value Per Share, released (in usd per share)	'	7.74
Weighted-Average Grant Date Fair Value Per Share, canceled (in usd per share)	'	7.88
Aggregate Intrinsic Value	'	'
Aggregate Intrinsic Value, beginning balance	'	64,443
Aggregate Intrinsic Value, RSUs released	'	22,477
Aggregate Intrinsic Value, ending balance	63,122	63,122
Aggregate Intrinsic Value, Expected to vest	61,021	61,021
Fiscal Year 2013 Grant [Member]	'	'
Number of Restricted Stock Units	'	'
Number of Restricted Stock Units, released (in shares)	0	-300

Stockholders_Equity_Summary_of2

Stockholders' Equity - Summary of Company's Equity Award Activity - PSUs (Details) (USD $)	9 Months Ended	12 Months Ended		9 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended	3 Months Ended	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2014	Dec. 28, 2013	Sep. 27, 2014	Sep. 27, 2014	Dec. 28, 2013	Sep. 27, 2014	Dec. 28, 2013	Sep. 27, 2014	Sep. 27, 2014
	PSUs [Member]	PSUs [Member]	PSUs [Member]	Minimum [Member]	Minimum [Member]	Maximum [Member]	Maximum [Member]	Fiscal Year 2013 Grant [Member]	Fiscal Year 2013 Grant [Member]
				PSUs [Member]	PSUs [Member]	PSUs [Member]	PSUs [Member]
Number of Performance Stock Units	'	'	'	'	'	'	'	'	'
Number of Restricted/Performance Stock Units, beginning balance (in shares)	721	'	'	'	'	'	'	'	'
Number of Restricted Stock Units, granted (in shares)	508	'	'	'	'	'	'	'	'
Number of Restricted Stock Units, released (in shares)	-255	'	'	'	'	'	'	0	-300
Number of Restricted Stock Units, canceled (in shares)	-97	'	'	'	'	'	'	'	'
Number of Restricted/Performance Stock Units, ending balance (in shares)	877	721	'	'	'	'	'	'	'
Number of Restricted Stock Units, Expected to vest (in shares)	659	'	'	'	'	'	'	'	'
Weighted- Average Grant Date Fair Value Per Share	'	'	'	'	'	'	'	'	'
Weighted-Average Grant Date Fair Value Per Share, beginning balance (in usd per share)	$7.04	'	$7.49	'	'	'	'	'	'
Weighted-Average Grant Date Fair Value Per Share, granted (in usd per share)	$7.53	'	'	$6.59	$6.27	$7.60	$7.06	'	'
Weighted-Average Grant Date Fair Value Per Share, released (in usd per share)	$6.36	'	'	'	'	'	'	'	'
Weighted-Average Grant Date Fair Value Per Share, canceled (in usd per share)	$7.18	'	'	'	'	'	'	'	'
Aggregate Intrinsic Value	'	'	'	'	'	'	'	'	'
Aggregate Intrinsic Value, beginning balance	$7,054	'	'	'	'	'	'	'	'
Aggregate Intrinsic Value, PSUs released	2,097	'	'	'	'	'	'	'	'
Aggregate Intrinsic Value, ending balance	9,298	7,054	'	'	'	'	'	'	'
Aggregate Intrinsic Value, Expected to vest	$6,994	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, NASDAQ Telecom Composite Index, Expected Volatility Rate	'	23.00%	'	'	'	'	'	'	'
Risk-free interest rate	'	0.42%	'	0.66%	'	0.71%	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correction with NASDAQ Telecom Composite Index	'	56.00%	'	'	'	'	'	'	'

Stockholders_Equity_Total_Stoc

Stockholders' Equity - Total Stock Based Compensation Cost for Instruments Granted but Not Yet Amortized (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options, Unrecognized Compensation Expense, Net	$317
Stock options, Weighted-Average Period (in years)	'1 year 6 months 15 days
Restricted Stock Units [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Unrecognized Compensation Expense, Net	30,599
Weighted-Average Period (in years)	'2 years 3 months 26 days
PSUs [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Unrecognized Compensation Expense, Net	$2,704
Weighted-Average Period (in years)	'1 year 6 months 26 days

Stockholders_Equity_Ranges_of_

Stockholders' Equity - Ranges of Estimated Values of Stock Options and Performance-Based Stock Options Granted (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

In Thousands, except Per Share data, unless otherwise specified

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Dec. 28, 2013

Sep. 27, 2014

Dec. 28, 2013

Sep. 27, 2014

Dec. 28, 2013

Stock Compensation Plan [Member]

Stock Compensation Plan [Member]

Stock Compensation Plan [Member]

Stock Compensation Plan [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

PSUs [Member]

PSUs [Member]

PSUs [Member]

PSUs [Member]

PSUs [Member]

PSUs [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-Average Grant Date Fair Value Per Share, granted (in usd per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$7.53

'

$6.59

$6.27

$7.60

$7.06

Volatility

'

'

'

'

'

'

52.00%

'

46.00%

49.00%

'

'

46.00%

46.00%

51.00%

49.00%

'

55.00%

49.00%

'

50.00%

'

Risk-free interest rate

'

'

'

'

'

'

1.30%

'

0.06%

0.10%

'

'

0.02%

0.10%

0.11%

0.14%

'

0.42%

0.66%

'

0.71%

'

Expected life

'

'

'

'

'

'

'4 years 4 months 2 days

'

'6 months

'6 months

'

'6 months

'3 months

'

'6 months

'

'

'

'

'

'

'

Estimated fair value

'

'

'

'

'

'

$3.85

'

$2.54

$3

'

'

$2.05

$1.87

$2.57

$3

'

'

'

'

'

'

Stock-based compensation expense

$7,371

$7,643

$20,847

$23,802

$108

$665

$623

$2,190

$1,092

$777

$2,726

$2,050

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, NASDAQ Telecom Composite Index, Expected Volatility Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correction with NASDAQ Telecom Composite Index

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

Stockholders_Equity_Estimated_

Stockholders' Equity - Estimated Fair Value of ESPP Shares (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

In Thousands, except Per Share data, unless otherwise specified

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Dec. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Dec. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

Sep. 27, 2014

Dec. 28, 2013

Sep. 27, 2014

Sep. 28, 2013

PSUs [Member]

PSUs [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

PSUs [Member]

PSUs [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

PSUs [Member]

PSUs [Member]

Employee Stock Purchase Plans [Member]

Employee Stock Purchase Plans [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-Average Grant Date Fair Value Per Share, granted (in usd per share)

'

'

'

'

$7.53

'

'

'

'

'

$6.59

$6.27

'

'

$7.60

$7.06

'

'

Volatility

'

'

'

'

'

55.00%

46.00%

49.00%

'

'

49.00%

'

46.00%

46.00%

50.00%

'

51.00%

49.00%

Risk-free interest rate

'

'

'

'

'

0.42%

0.06%

0.10%

'

'

0.66%

'

0.02%

0.10%

0.71%

'

0.11%

0.14%

Expected life

'

'

'

'

'

'

'6 months

'6 months

'

'6 months

'

'

'3 months

'

'

'

'6 months

'

Estimated fair value

'

'

'

'

'

'

$2.54

$3

'

'

'

'

$2.05

$1.87

'

'

$2.57

$3

Stock-based compensation expense

$7,371

$7,643

$20,847

$23,802

'

'

$1,092

$777

$2,726

$2,050

'

'

'

'

'

'

'

'

Stockholders_Equity_Summary_of3

Stockholders' Equity - Summary of Effects of Stock-Based Compensation on Company's Balance Sheets (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Stock-Based Compensation Effects in Inventory [Member]	'	'
Effects Of Stock Based Compensation [Line Items]	'	'
Effects Of Stock Based Compensation	$3,160	$3,189
Stock-Based Compensation Effects in Deferred Inventory Cost [Member]	'	'
Effects Of Stock Based Compensation [Line Items]	'	'
Effects Of Stock Based Compensation	13	15
Stock-Based Compensation Effects in Fixed Assets [Member]	'	'
Effects Of Stock Based Compensation [Line Items]	'	'
Effects Of Stock Based Compensation	$126	$145

Stockholders_Equity_Summary_of4

Stockholders' Equity - Summary of Effects of Stock-Based Compensation on Company's Statements of Operations (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014		Sep. 28, 2013		Sep. 27, 2014		Sep. 28, 2013
Effects Of Stock Based Compensation [Line Items]	'		'		'		'
Stock-based compensation effects included in net income (loss) before income taxes	$6,372		$6,516		$18,133		$19,383
Cost of revenue - amortization from balance sheet	999	[1]	1,127	[1]	2,714	[1]	4,419
Allocated Share-based Compensation Expense	7,371		7,643		20,847		23,802
Cost of revenue	'		'		'		'
Effects Of Stock Based Compensation [Line Items]	'		'		'		'
Stock-based compensation effects included in net income (loss) before income taxes	492		422		1,421		1,382
Research and development	'		'		'		'
Effects Of Stock Based Compensation [Line Items]	'		'		'		'
Stock-based compensation effects included in net income (loss) before income taxes	2,270		2,434		6,488		8,175
Sales and marketing	'		'		'		'
Effects Of Stock Based Compensation [Line Items]	'		'		'		'
Stock-based compensation effects included in net income (loss) before income taxes	1,982		1,853		5,517		5,659
General and administration	'		'		'		'
Effects Of Stock Based Compensation [Line Items]	'		'		'		'
Stock-based compensation effects included in net income (loss) before income taxes	$1,628		$1,807		$4,707		$4,167
[1]	Stock-based compensation expense deferred to inventory and deferred inventory costs in prior periods and recognized in the current period.

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Provision for income taxes	$205	$308	$1,070	$1,240
Pre-tax income (loss)	$5,048	$3,655	$6,319	($20,701)

Segment_Information_Revenue_an

Segment Information - Revenue and Long-Lived Assets by Geographic Region (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014	Sep. 28, 2013	Sep. 27, 2014	Sep. 28, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	$173,559	$142,020	$481,773	$405,030
Operating Segments [Member] | United States [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	120,769	103,113	367,802	270,437
Operating Segments [Member] | Other Americas [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	9,230	2,024	17,526	6,544
Operating Segments [Member] | Americas [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	129,999	105,137	385,328	276,981
Operating Segments [Member] | Europe, Middle East and Africa [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	34,131	32,262	78,978	103,022
Operating Segments [Member] | Asia Pacific and Japan [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	$9,429	$4,621	$17,467	$25,027

Segment_Information_Property_P

Segment Information - Property, Plant and Equipment, Net (Details) (USD $)	Sep. 27, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Geographic Information For Property Plant And Equipment [Line Items]	'	'
Total property, plant and equipment, net	$74,964	$79,668
Operating Segments [Member] | United States [Member]	'	'
Geographic Information For Property Plant And Equipment [Line Items]	'	'
Total property, plant and equipment, net	72,428	76,850
Operating Segments [Member] | Other Americas [Member]	'	'
Geographic Information For Property Plant And Equipment [Line Items]	'	'
Total property, plant and equipment, net	237	319
Operating Segments [Member] | Europe, Middle East and Africa [Member]	'	'
Geographic Information For Property Plant And Equipment [Line Items]	'	'
Total property, plant and equipment, net	943	1,451
Operating Segments [Member] | Asia Pacific and Japan [Member]	'	'
Geographic Information For Property Plant And Equipment [Line Items]	'	'
Total property, plant and equipment, net	$1,356	$1,048

Guarantees_Additional_Informat

Guarantees - Additional Information (Details)	9 Months Ended
	Sep. 27, 2014
Minimum [Member]	'
Guarantor Obligations [Line Items]	'
Product warranty period	'1 year
Maximum [Member]	'
Guarantor Obligations [Line Items]	'
Product warranty period	'5 years

Guarantees_Activity_Related_to

Guarantees - Activity Related to Product Warranty (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 27, 2014		Sep. 28, 2013		Sep. 27, 2014		Sep. 28, 2013
Movement in Standard Product Warranty Accrual [Roll Forward]	'		'		'		'
Beginning balance	$27,948		$19,701		$22,908		$16,482
Charges to operations	5,820		5,220		18,181		16,646
Utilization	-2,312		-2,645		-7,924		-6,783
Change in estimate	-3,650	[1]	886	[1]	-5,359	[1]	-3,183	[1]
Balance at the end of the period	$27,806		$23,162		$27,806		$23,162
[1]	The Company records hardware warranty liabilities based on the latest quality and cost information available as of that date. The changes in estimate shown here are due to changes in overall actual failure rates and the resulting impact of these changes on the Company’s estimate of expected future returns, as well as changes in the estimated cost and the mix of new versus used units related to replacement of failed units.